Skip to content
February 7, 2013
In the News
Oral insulin developer Oramed to list on Nasdaq
http://www.globes.co.il/en/article-1000820748
Prev
Previous
Type 2: Oramed Sends Oral Insulin Test Request to FDA
Next
Groundbreaking Insulin Pill Nearing Market
Next
You may also be interested
Insulin Pill for Diabetes Inches Closer to Reality
April 15, 2013
In the News
Medwire News: Novel oral insulin shows promise for type 2 diabetes
September 25, 2020
In the News
Oramed – An Early-Stage Biotech Company With Huge Potential
July 17, 2013
In the News
Join our mailing list
Email
SUBSCRIBE
+1-844-9-ORAMED
office@oramed.com
Linkedin-in
Facebook-f
Twitter
Youtube
Home
About
Technology
Pipeline
Video Library
Contact us
NEWS
Press Releases
In the News
Scientific Articles and Abstracts
Events & Presentations
INVESTORS
Corporate presentation
Investor Relations
SEC filings
Investor FAQ
Governance documents
Annual shareholder meeting
Investor tools
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset
